i
Loading Page
loading, please wait

Select Year:

Home > DC Providers
placeholder image of provider

Dr. Deepnarayan Tiwarri, MD

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology
Howard University College of Medicine (1996)
Professional interests include: thyroid cancer, bleeding disorders, liver cancer, and more.
9333 Healthcare Way
Largo, MD 20774

Dr. Deepnarayan Tiwarri, MD is a medical oncologist in Washington, DC specializing in medical oncology, adult oncology and adult hematology. He graduated from Howard University College of Medicine in 1996 and has 29 years of experience. Dr. Deepnarayan Tiwarri, MD is affiliated with MedStar Georgetown University Hospital, University of Maryland Medical System, Luminis Health, MedStar Washington Hospital Center, MedStar Southern Maryland Hospital Center, MedStar Health and MARYLAND ONCOLOGY HEMATOLOGY PA.

View Doctor's Full Profile (240) 677-8300

Office Locations

MedStar Health

110 Irving Street Nw
Washington, DC 20010
(202) 877-7000
open_in_new

MedStar Health

3800 Reservoir Road Nw
Washington, DC 20007
(202) 444-2000
open_in_new
7503 Surratts Road
Clinton, MD 20735
open_in_new
8926 Woodyard Road Suite 201
Clinton, MD 20735
(301) 868-7911
(301) 868-2285
open_in_new

University of Maryland Medical System

9333 Healthcare Way
Largo, MD 20774
(240) 677-8300
open_in_new

Some issues Dr. Deepnarayan Tiwarri, MD can help you with:

Blood Transfusion

Blood transfusions typically treat those who experience a substantial loss of blood from an injury or surgical procedure, or those who suffer from conditions that alter the blood supply or blood components. For example, a blood transfusion may contribute additional red blood cells to someone with anemia, a condition where the body does not produce enough red blood cells. Other conditions may include:

  • Hemophilia (blood clotting disorder)
  • Leukemia
  • Liver disease
  • Sickle cell disease (misshapen red blood cells)
  • Thrombocytopenia (lack of platelets)

When a patient has sufficient blood volume and lacks one or more components, a complete blood count (CBC) test can help determine if a patient requires a transfusion by measuring four blood components: red blood cells, white blood cells, platelets, and hemoglobin. If any of the patient's component counts is significantly below a standard range, the patient will likely need a blood transfusion. The complete blood count test uses a needle to extract a small amount of blood for testing.

Blood transfusion recipients should be tested for their blood type, which is one of four different types: type A, B, AB, or O. Patients with A, B, and O blood can only receive a blood donation matching their blood type or of O blood, which is known as the universal donor. Those with AB blood are considered "universal recipients"; they may receive A, B, AB, or O blood. Further complicating blood types is the presence or absence of the RhD antigen, adding a positive or negative modifier that should also be considered. Incompatible blood donations may cause transfusion sickness, such as a hemolytic reaction, where the body fights the donated red blood cells.

In certain emergency or trauma situations, medical teams often do not perform a complete blood count (CBC) test or blood type test. In those cases, patients are often given O negative blood, which is universally accepted. Some patients have their blood type on a medical card or bracelet, allowing emergency medical teams to issue compatible blood without testing.

Transfusions are performed by inserting a needle attached to an intravenous line (IV) into a vein in the body. This IV line is attached to a bag of blood that steadily dispenses blood into the patient's bloodstream. The type, volume, and components of donated blood depend on the patient's condition and needs. After the transfusion is complete, patients are generally permitted to resume normal activity, unless prohibited by a condition or injury. Some patients may experience bruising or soreness around the area that the needle was inserted.

At times, a second complete blood count test is performed to determine if the transfusion has brought patients' component counts to normal levels. Some patients may require multiple blood transfusions to reach a healthy blood volume and blood component count.

Once patients' blood volumes and components reach sufficient levels, they will generally begin to feel better. Patients of all ages, from newborn infants to elderly adults, can receive a blood transfusion.

Breast Biopsy

Breast biopsy is a procedure where a small sample of tissue is collected from the breast for testing. A physician may prescribe a breast biopsy for a variety of reasons, but they are most frequently prescribed for a lump found in the breast. Biopsy samples extracted are examined by pathologists in a laboratory setting and are tested to determine if they are cancerous or benign, or indicative of some other condition. Depending on the lab results, physicians may prescribe additional treatment. Other circumstances which may prompt a breast biopsy include:

  • Mammograms that detect other unusual features in the chest, such as a cyst or calcium deposit
  • Breast scans or ultrasounds that display abnormalities
  • Nipple changes, such as scaling, crusting, or bloody discharge

Breast biopsies are collected through several different procedures and the specific type of biopsy that a patient receives depends on the size, location, and features of a breast lump or irregularity. The three main methods of collecting a breast biopsy include:

  • Fine needle aspiration (FNA biopsy), where a thin needle is directed into a breast lump or abnormality, extracting a small sample of tissue or liquid
  • Core needle biopsy (CNB biopsy), where a hollow needle is directed into a breast lump or abnormality, extracting cylinders of tissue called "cores"
  • Open (surgical) biopsy, where a breast lump is removed through an incision in the breast

Fine needle aspiration (FNA) and core needle biopsy (CNB) are sometimes image-guided, where a mammogram, ultrasound, or MRI helps direct the physician performing the needle extraction.

Fine needle aspiration, the most common biopsy method, generally requires few patient preparations. It is recommended patients avoid using lotion, deodorant, and perfume prior to their biopsy procedure. FNA biopsy is performed with local anesthesia (topical numbing cream) and typically has a quick recovery, but patients may experience soreness for a few days. Core needle biopsy extracts slightly more tissue than an FNA biopsy.

Open (surgical) biopsy is more invasive and requires general anesthesia, where patients are put to sleep during the procedure. Patients must fast prior to the surgery. After the biopsy is performed, patients are monitored in a recovery room for a time before being discharged, when they will need someone else to provide transportation.

Although some may consider breast biopsy to be a simple procedure, it can catch critical issues - particularly breast cancer - that impact wellness. If a breast biopsy reveals an underlying condition like life-threatening cancer, patients can receive the diagnosis and medical treatment that is necessary for their long-term health.

Thrombocytosis (High Platelet Count)

Thrombocytosis is a disorder where people have too high of a concentration of platelets. Excess platelets can cause blood to clot in the veins. Blood clots in the veins are particularly dangerous, as they can obstruct blood flow and cause heart attacks and strokes. Thrombocytosis has two forms:

  • Thrombocythemia, also referred to as primary or essential thrombosis (ET), develops from irregular bone marrow cells that produce too many platelets. The cause of these bone marrow cells is unknown.
  • Reactive thrombosis (RT), also referred to as secondary thrombosis, arises from a different condition such as cancer, anemia, spleen removal, or infection. It is most common in older adults, but can occur in people of all ages. Symptoms of reactive thrombosis may gradually develop over time and typically include bruising, gum bleeding, and blood clotting.

If a doctor suspects a patient has thrombocytosis, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytosis can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.

Patients with high platelet counts are frequently prescribed a daily dose of over-the-counter medication aspirin to thin the blood. Platelet-lowering medications, such as hydroxyurea and Intron A, may reduce the likelihood of blood clot formation. Excess platelets may also be removed from the blood by a procedure called plateletpheresis or platelet reduction apheresis, where blood is drawn, circulated into a centrifuge that separates the blood components, and returned to the body with some platelets extracted. Plateletpheresis is a rare procedure reserved for patients who have severe clotting.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with thrombocytosis are advised to drink plenty of water, exercise regularly, and to avoid smoking. Many people with thrombocytosis live healthy and fulfilling lives with proper treatment and precautions.

Noteworthy Medicare Patient Procedures Performed by Dr. Deepnarayan Tiwarri, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

antineoplastic hormone therapy
biological response modifier therapy
blood draw
complete blood count
intravenous chemotherapy
intravenous infusion
lab tests
phlebotomy for lab tests
phosphorus blood test
port flush
prothrombin time test
rheumatoid factor test
thyroid blood test
total IgA test
total IgG test
total PSA test
uric acid blood test

By Affordability:

antineoplastic hormone therapy
carcinoembryonic antigen test
flow cytometry
hormone therapy
hospital care
IgA test
IgD test
IgG test
IgM test
immunoglobulin tests
inpatient care
inpatient hospital care
iron tests
lactate dehydrogenase test
liver function tests
metabolic panel
port flush
quantitative Ig tests
thyroid blood test
thyroid function tests
total IgA test
total IgG test
uric acid test

In 2023, among providers in related specialties within District of Columbia, Dr. Deepnarayan Tiwarri, MD performed more antineoplastic hormone therapy, biological response modifier (BRM) therapy, blood draw, complete blood count (CBC), intravenous (IV) chemotherapy, intravenous (IV) infusion, lab tests, phlebotomy for lab tests, phosphorus blood test, port flush, prothrombin time (PT) test, rheumatoid factor (RF) test, thyroid blood test, total IgA test, total IgG test, total PSA test, and uric acid blood test procedures for Medicare patients than 95% of them and he also had a list price for antineoplastic hormone therapy, carcinoembryonic antigen (CEA) test, flow cytometry, hormone therapy, hospital care, IgA test, IgD test, IgG test, IgM test, immunoglobulin tests, inpatient care, inpatient hospital care (for patient admitted to hospital), iron tests, lactate dehydrogenase (LDH) test, liver function tests (LFTs), metabolic panel, port flush, quantitative Ig tests, thyroid blood test, thyroid function tests, total IgA test, total IgG test, and uric acid test that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Affordability:

folic acid tests
serum folate test
uric acid blood test

In 2023, Dr. Deepnarayan Tiwarri, MD had a list price for folic acid tests, serum folate test, and uric acid blood test that was lower than the list prices billed to Medicare by 90% of providers in related specialties within District of Columbia. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Affordability:

beta-2 microglobulin test
vitamin B12 test

In 2013, Dr. Deepnarayan Tiwarri, MD had a list price for beta-2 microglobulin (B2M) test, and vitamin B12 test that was lower than the list prices billed to Medicare by 75% of providers in related specialties within District of Columbia. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2013 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

aspiration 14
biological response modifier (BRM) therapy 264
blood draw 1344
bone marrow tests 28
chemotherapy 264
diagnostic procedures 28
doctor visit 1296
hormone therapy 28
hospital care 130
inpatient care 130
lab tests 12878
minimally invasive procedures 565
port flush 111
preventive care 13
vaccines 13

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 374
Female 691
Ethnicity
Non-Hispanic White 367
Black 656
Hispanic 18
Asian 0
Other 0
Native American 0
Age
From 65 to 74 470
From 75 to 84 344
85 and over 117
Less than 65 134

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2013

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2013 were hypertension, high cholesterol, diabetes and chronic kidney disease.

Hypertension 75
High Cholesterol 64
Stroke 6
Ischemic Heart Disease 38
Depression 11
Chronic Kidney Disease 48
Asthma 8
Osteoperosis 11
Atrial Fibrilation 10
Heart Failure 25
Chronic Obstructive Pulmonary Disease 16
Diabetes 50
Dementia 10
Cancer 37

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2014 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

biological response modifier (BRM) therapy 278
blood draw 1011
chemotherapy 278
doctor visit 1211
hospital care 133
inpatient care 133
lab tests 5696
minimally invasive procedures 535
port flush 137

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 373
Female 662
Ethnicity
Non-Hispanic White 358
Black 651
Hispanic 0
Asian 11
Other 0
Native American 0
Age
From 65 to 74 446
From 75 to 84 354
85 and over 119
Less than 65 116

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2014

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2014 were hypertension, high cholesterol, diabetes and chronic kidney disease.

Hypertension 75
High Cholesterol 63
Stroke 6
Ischemic Heart Disease 39
Depression 11
Chronic Kidney Disease 46
Asthma 9
Osteoperosis 8
Atrial Fibrilation 10
Heart Failure 24
Chronic Obstructive Pulmonary Disease 14
Diabetes 48
Dementia 10
Cancer 37

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2015 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

biological response modifier (BRM) therapy 271
chemotherapy 271
doctor visit 1301
hormone therapy 30
hospital care 180
inpatient care 180
lab tests 5378
minimally invasive procedures 507
port flush 196
preventive care 11
vaccines 11

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 612
Female 1176
Ethnicity
Non-Hispanic White 584
Black 1150
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 790
From 75 to 84 578
85 and over 214
Less than 65 206

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2015

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2015 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension 75
High Cholesterol 63
Stroke 6
Ischemic Heart Disease 36
Depression 13
Chronic Kidney Disease 50
Asthma 14
Osteoperosis 11
Atrial Fibrilation 12
Heart Failure 24
Chronic Obstructive Pulmonary Disease 17
Diabetes 48
Dementia 11
Cancer 38

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2016 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

aspiration 13
biological response modifier (BRM) therapy 313
bone marrow tests 27
chemotherapy 313
diagnostic procedures 27
doctor visit 1511
hospital care 256
inpatient care 256
lab tests 5674
minimally invasive procedures 466
port flush 122
preventive care 15
vaccines 15

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 360
Female 636
Ethnicity
Non-Hispanic White 312
Black 653
Hispanic 12
Asian 0
Other 0
Native American 0
Age
From 65 to 74 439
From 75 to 84 328
85 and over 108
Less than 65 121

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2016

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2016 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension 75
High Cholesterol 64
Stroke 8
Ischemic Heart Disease 41
Depression 14
Chronic Kidney Disease 54
Asthma 22
Osteoperosis 9
Atrial Fibrilation 11
Heart Failure 26
Chronic Obstructive Pulmonary Disease 19
Diabetes 48
Dementia 13
Cancer 40

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2017 were lab tests, minimally invasive procedures, hospital care and inpatient care.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

aspiration 17
biological response modifier (BRM) therapy 406
bone marrow tests 35
chemotherapy 406
diagnostic procedures 35
doctor visit 1820
hospital care 438
inpatient care 438
lab tests 2077
minimally invasive procedures 583
port flush 77

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 375
Female 699
Ethnicity
Non-Hispanic White 350
Black 678
Hispanic 19
Asian 13
Other 14
Native American 0
Age
From 65 to 74 457
From 75 to 84 376
85 and over 128
Less than 65 113

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2017

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2017 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension 75
High Cholesterol 60
Stroke 7
Ischemic Heart Disease 41
Depression 19
Chronic Kidney Disease 57
Asthma 10
Osteoperosis 10
Atrial Fibrilation 13
Heart Failure 27
Chronic Obstructive Pulmonary Disease 20
Diabetes 48
Dementia 14
Cancer 36

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

biological response modifier (BRM) therapy 649
blood draw 1074
chemotherapy 649
doctor visit 2199
hospital care 344
inpatient care 344
lab tests 6553
minimally invasive procedures 987
port flush 106

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 418
Female 764
Ethnicity
Non-Hispanic White 387
Black 745
Hispanic 19
Asian 12
Other 19
Native American 0
Age
From 65 to 74 500
From 75 to 84 430
85 and over 145
Less than 65 107

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2018

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2018 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension 75
High Cholesterol 67
Stroke 8
Ischemic Heart Disease 41
Depression 15
Chronic Kidney Disease 58
Asthma 9
Osteoperosis 10
Atrial Fibrilation 12
Heart Failure 28
Chronic Obstructive Pulmonary Disease 19
Diabetes 47
Dementia 13
Cancer 37

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

biological response modifier (BRM) therapy 513
blood draw 1486
chemotherapy 513
doctor visit 2083
hospital care 205
inpatient care 205
lab tests 8915
minimally invasive procedures 913
port flush 100

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 379
Female 717
Ethnicity
Non-Hispanic White 334
Black 718
Hispanic 16
Asian 0
Other 14
Native American 0
Age
From 65 to 74 437
From 75 to 84 427
85 and over 134
Less than 65 98

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2019

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2019 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension 75
High Cholesterol 66
Stroke 8
Ischemic Heart Disease 39
Depression 16
Chronic Kidney Disease 57
Asthma 8
Osteoperosis 10
Atrial Fibrilation 10
Heart Failure 26
Chronic Obstructive Pulmonary Disease 18
Diabetes 47
Dementia 14
Cancer 36

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

biological response modifier (BRM) therapy 706
blood draw 2277
chemotherapy 706
doctor visit 2329
hormone therapy 33
hospital care 117
inpatient care 117
lab tests 9638
minimally invasive procedures 1075
port flush 93
thyroid function tests 79

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 402
Female 740
Ethnicity
Non-Hispanic White 344
Black 755
Hispanic 16
Asian 13
Other 14
Native American 0
Age
From 65 to 74 455
From 75 to 84 437
85 and over 131
Less than 65 119

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2020

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2020 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension 75
High Cholesterol 66
Stroke 7
Ischemic Heart Disease 37
Depression 13
Chronic Kidney Disease 55
Asthma 8
Osteoperosis 11
Atrial Fibrilation 10
Heart Failure 23
Chronic Obstructive Pulmonary Disease 15
Diabetes 47
Dementia 10
Cancer 33

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

biological response modifier (BRM) therapy 743
blood draw 2766
chemotherapy 743
doctor visit 2542
hospital care 181
inpatient care 181
lab tests 11676
minimally invasive procedures 1281
port flush 124
thyroid function tests 90

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 388
Female 791
Ethnicity
Non-Hispanic White 330
Black 796
Hispanic 18
Asian 0
Other 23
Native American 0
Age
From 65 to 74 495
From 75 to 84 439
85 and over 133
Less than 65 112

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2021

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2021 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension 75
High Cholesterol 70
Stroke 7
Ischemic Heart Disease 38
Depression 14
Chronic Kidney Disease 54
Asthma 8
Osteoperosis 11
Atrial Fibrilation 11
Heart Failure 22
Chronic Obstructive Pulmonary Disease 16
Diabetes 47
Dementia 11
Cancer 36

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

biological response modifier (BRM) therapy 704
blood draw 2487
chemotherapy 704
doctor visit 2522
hormone therapy 33
hospital care 64
inpatient care 64
lab tests 12037
minimally invasive procedures 1248
port flush 91
thyroid function tests 86

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 443
Female 843
Ethnicity
Non-Hispanic White 373
Black 865
Hispanic 17
Asian 12
Other 19
Native American 0
Age
From 65 to 74 509
From 75 to 84 492
85 and over 158
Less than 65 127

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2022

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2022 were high cholesterol, hypertension, diabetes and cancer.

Hypertension 75
High Cholesterol 75
Stroke 12
Ischemic Heart Disease 28
Depression 13
Chronic Kidney Disease 42
Asthma 12
Osteoperosis 13
Atrial Fibrilation 19
Heart Failure 20
Chronic Obstructive Pulmonary Disease 20
Diabetes 46
Dementia 8
Cancer 42

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

The top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC during 2023 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

biological response modifier (BRM) therapy 657
blood draw 2775
chemotherapy 657
doctor visit 2120
hormone therapy 61
hospital care 115
inpatient care 115
lab tests 12779
minimally invasive procedures 1169
port flush 80
thyroid function tests 31

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 413
Female 820
Ethnicity
Non-Hispanic White 350
Black 825
Hispanic 18
Asian 14
Other 26
Native American 0
Age
From 65 to 74 467
From 75 to 84 478
85 and over 173
Less than 65 115

Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD in 2023

The most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated during 2023 were high cholesterol, hypertension, diabetes and cancer.

Hypertension 75
High Cholesterol 75
Stroke 13
Ischemic Heart Disease 29
Depression 16
Chronic Kidney Disease 42
Asthma 12
Osteoperosis 15
Atrial Fibrilation 19
Heart Failure 20
Chronic Obstructive Pulmonary Disease 19
Diabetes 49
Dementia 10
Cancer 42

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2013 - 2023

Volume of procedures performed by Dr. Deepnarayan Tiwarri, MD for Medicare patients.

The highest averages for the top procedures that Dr. Deepnarayan Tiwarri, MD treated as a medical oncologist in Washington, DC were lab tests, blood draw, minimally invasive procedures and chemotherapy.

aspiration 14
biological response modifier (BRM) therapy 500
blood draw 1902
bone marrow tests 30
chemotherapy 500
diagnostic procedures 30
doctor visit 1903
hormone therapy 37
hospital care 196
inpatient care 196
lab tests 8481
minimally invasive procedures 848
preventive care 13
thyroid function tests 71
vaccines 13

Average Medicare Patient Data From 2013 - 2023

Information about Medicare patients treated by Dr. Deepnarayan Tiwarri, MD.

Gender
Male 412
Female 776
Ethnicity
Black / African American 772
Asian / Pacific Islander 6
Non-Hispanic White 371
Hispanic 13
Native American / Alaskan Native 0
Other 11
Age
75 to 84 425
85 and over 141
Less than 65 124
65 to 74 496

Average of Total of Conditions of Medicare patients treated by Dr. Deepnarayan Tiwarri, MD From 2013 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Deepnarayan Tiwarri, MD treated were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension 75
High Cholesterol 66
Stroke 8
Ischemic Heart Disease 37
Depression 14
Chronic Kidney Disease 51
Asthma 10
Osteoporosis 10
Heart Failure 24
Chronic Obstructive Pulmonary Disease 17
Diabetes 47
Atrial Fibrillation 12
Dementia 11
Cancer 37

Education & Training

Dr. Deepnarayan Tiwarri, MD graduated from Howard University College of Medicine in 1996. He completed residency at Washington Hospital Center. He is certified by the American Board of Internal Medicine - Hematology, American Board of Internal Medicine - Medical Oncology and has a state license in Maryland.

Medical School: Howard University College of Medicine (1996)

Residency: Washington Hospital Center (2000)

Board Certification: American Board of Internal Medicine - Hematology, American Board of Internal Medicine - Medical Oncology (2004)

Licensed In: Maryland

Affiliations & Hospitals

Dr. Deepnarayan Tiwarri, MD is associated with these hospitals and organizations:

MedStar Georgetown University Hospital
University of Maryland Medical System
Luminis Health
MedStar Washington Hospital Center
MedStar Southern Maryland Hospital Center
MedStar Health
MARYLAND ONCOLOGY HEMATOLOGY PA

Ratings & Reviews

Dr. Deepnarayan Tiwarri, MD does not have any reviews yet, be the first to leave a review of Dr. Deepnarayan Tiwarri, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Deepnarayan Tiwarri, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Payments by Company
Novartis Pharmaceuticals Corporation $8,995 PROMACTA
$7,861 		TASIGNA
$317 		NON BRAND
$139 		Fabhalta
$116 		RYDAPT
$93 		Other
$468
Genentech USA, Inc. $4,458 Venclexta
$152 		TECENTRIQ
$140 		Avastin
$59 		TARCEVA
$43 		Perjeta
$43 		Other
$4,021
Amgen Inc. $4,205 Vectibix
$2,133 		XGEVA
$1,133 		Neulasta
$800 		Kyprolis
$94 		LUMAKRAS
$34 		Other
$11
Heron Therapeutics, Inc. $3,909 SUSTOL
$3,859 		cinvanti
$50
Rigel Pharmaceuticals, Inc. $2,461 Tavalisse
$2,461
Other $14,000 Monoferric
$1,833 		Stivarga
$1,230 		IMBRUVICA
$812 		ELIQUIS
$603 		OPDIVO
$345 		Other
$9,176
Types of Payments
Food and Beverage $14,304
Consulting Fee $13,850
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,400
Travel and Lodging $4,114
Honoraria $1,167
Other $193

Research Payments

Dr. Deepnarayan Tiwarri, MD has received 22 research payments totaling $64,262.

Biography

Dr. Deepnarayan Tiwarri is an adult hematology, adult oncology, and medical oncology specialist. He graduated from Howard University College of Medicine and then he performed his residency at Washington Hospital Center. Dr. Tiwarri's hospital/clinic affiliations include the University of Maryland Medical System, MedStar Southern Maryland Hospital Center, and Luminis Health.

Other Providers in Washington, DC